tiprankstipranks
Trending News
More News >
Extendicare (TSE:EXE)
TSX:EXE
Canadian Market
Advertisement

Extendicare (EXE) Earnings Dates, Call Summary & Reports

Compare
207 Followers

Earnings Data

Report Date
Nov 12, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.2
Last Year’s EPS
0.19
Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 06, 2025|
% Change Since: 5.77%|
Earnings Call Sentiment|Positive
The earnings call reflected strong growth in key areas such as Adjusted EBITDA, home health care volumes, and successful acquisitions. However, there were challenges with the loss of revenue from closed Class C homes and a decline in Managed Services revenue. Despite these challenges, the positive developments and strategic acquisitions indicate a strong position for future growth.
Company Guidance -
Q3 2025
During Extendicare Inc.'s Second Quarter 2025 Analyst Conference Call, the company provided several key financial metrics and strategic updates. Adjusted EBITDA increased to $39.8 million, a 3% increase over the previous year, and a notable 15.4% increase when excluding out-of-period items. The home health care segment led with a 10.9% increase in average daily volumes and a 90 basis point improvement in NOI margin to 13.5%. The company's AFFO rose to $0.29 per share, marking a 23.1% year-over-year increase, with a dividend payout ratio of 46% over the trailing 12 months. Extendicare completed two significant acquisitions: nine long-term care homes and a parcel of land for $41.9 million, adding 822 long-term care beds and 574 private pay retirement beds, and the acquisition of Closing the Gap for $75.1 million, which added over 1,200 caregivers and is expected to contribute $9.8 million in annualized NOI. The company enhanced its redevelopment strategy with six new projects in Ontario and increased its senior secured credit facility by $100 million, providing substantial liquidity for future growth.
Strong Growth in Adjusted EBITDA and AFFO
Adjusted EBITDA increased to $39.8 million, up 3% over the prior year. Excluding out-of-period items, adjusted EBITDA increased by 15.4%. AFFO increased to $0.29 per share, up 23.1% year-over-year.
Successful Acquisitions and Expansion
Completed acquisition of 9 Class C long-term care homes and a parcel of land from Revera for $41.9 million in cash, adding 822 long-term care beds and 574 private pay retirement beds. Expected to add approximately $13 million in annualized NOI.
Home Health Care Segment Growth
Average daily volumes in home health care were up 10.9% from the prior year, and NOI margin improved by 90 basis points to 13.5%.
Increase in Revenue and NOI
Consolidated Q2 revenue increased by 10% to $383.4 million. Excluding out-of-period items, Q2 NOI improved by $6.3 million or 12.9% to $55 million.
Managed Services Expansion
Third-party and joint venture beds serviced by SGP grew 5.9% from last year, now servicing over 149,000 beds.

Extendicare (TSE:EXE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:EXE Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 12, 2025
2025 (Q3)
0.20 / -
0.19
Aug 06, 2025
2025 (Q2)
0.18 / 0.37
0.2928.62% (+0.08)
May 06, 2025
2025 (Q1)
0.16 / 0.18
0.1517.33% (+0.03)
Feb 27, 2025
2024 (Q4)
0.17 / 0.23
0.1130.00% (+0.13)
Nov 12, 2024
2024 (Q3)
- / 0.19
0.1435.71% (+0.05)
Aug 12, 2024
2024 (Q2)
- / 0.29
0.021350.00% (+0.27)
May 15, 2024
2024 (Q1)
- / 0.15
0.147.14% (<+0.01)
Mar 08, 2024
2023 (Q4)
- / 0.10
-0.09211.11% (+0.19)
Nov 09, 2023
2023 (Q3)
- / 0.14
-0.04450.00% (+0.18)
Aug 10, 2023
2023 (Q2)
- / 0.02
0.04-50.00% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:EXE Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 06, 2025
C$12.69C$12.66-0.24%
May 06, 2025
C$14.41C$13.56-5.90%
Feb 27, 2025
C$11.41C$12.22+7.10%
Nov 12, 2024
C$9.19C$9.87+7.40%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Extendicare (TSE:EXE) report earnings?
Extendicare (TSE:EXE) is schdueled to report earning on Nov 12, 2025, After Close (Confirmed).
    What is Extendicare (TSE:EXE) earnings time?
    Extendicare (TSE:EXE) earnings time is at Nov 12, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:EXE EPS forecast?
          TSE:EXE EPS forecast for the fiscal quarter 2025 (Q3) is 0.2.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis